http://www.newstin.co.uk/uk/pharmaceuticals Organizing the News Copyright © 2006 I2S a.s. Copyright © 2006 I2S a.s. http://www.newstin.co.uk/tag/uk/91081860 PITTSBURGH, December 02, 2008 /PRNewswire-FirstCall/ -- Mylan Inc. today announced that it and its subsidiary, Mylan Pharmaceuticals Inc., have entered into a settlement agreement with Novartis Pharmaceuticals Corp., Novartis... Tue, 02 Dec 2008 15:26:00 GMT http://www.newstin.co.uk/tag/uk/91081860 2008-12-02T15:26:00Z http://www.newstin.co.uk/tag/uk/90993675 Vical Incorporated (Nasdaq: VICL) announced the receipt of a $1.0 million milestone payment from Merck & Co., Inc. based on Merck's planned initiation of a Phase I clinical trial of an investigational plasmid DNA (pDNA) cancer... Tue, 02 Dec 2008 08:38:00 GMT http://www.newstin.co.uk/tag/uk/90993675 2008-12-02T08:38:00Z http://www.newstin.co.uk/tag/uk/91036932 Stocks mentioned in this article SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) today announced the appointment of Gary Titus as Chief Financial Officer and Senior Vice President, Finance, effective December 8, 2008. In this... Tue, 02 Dec 2008 11:56:00 GMT http://www.newstin.co.uk/tag/uk/91036932 2008-12-02T11:56:00Z http://www.newstin.co.uk/tag/uk/91019603 GeoVax Labs, Inc. (OTC Bulletin Board: GOVX), an Atlanta-based biotechnology company developing human vaccines for diseases caused by HIV-1 (Human Immunodeficiency Virus) and other infectious agents, announced today that the... Tue, 02 Dec 2008 11:13:22 GMT http://www.newstin.co.uk/tag/uk/91019603 2008-12-02T11:13:22Z http://www.newstin.co.uk/tag/uk/91120182 SOPHIA ANTIPOLIS, France, December 02, 2008 /PRNewswire-FirstCall/ -- Naproxcinod is NicOx' lead investigational product and the first compound in the Cyclooxygenase-Inhibiting Nitric Oxide-Donating (CINOD) class of... Tue, 02 Dec 2008 18:43:00 GMT http://www.newstin.co.uk/tag/uk/91120182 2008-12-02T18:43:00Z http://www.newstin.co.uk/tag/uk/91019670 America's pharmaceutical research companies are testing 109 medicines and vaccines to treat or prevent HIV/AIDS and related conditions, according to a report released today by the Pharmaceutical Research and Manufacturers of... Tue, 02 Dec 2008 11:13:34 GMT http://www.newstin.co.uk/tag/uk/91019670 2008-12-02T11:13:34Z http://www.newstin.co.uk/tag/uk/91101284 BRUSSELS, Belgium, Dec. 2, 2008 at 07:00 AM (CET) - UCB announced today that its CDP6038 antibody drug candidate targeting IL-6 has achieved a key milestone as the first subjects have been dosed in its Phase 1 'first in human'... Tue, 02 Dec 2008 17:09:00 GMT http://www.newstin.co.uk/tag/uk/91101284 2008-12-02T17:09:00Z http://www.newstin.co.uk/tag/uk/91055668 Tuesday December 2, 8:00 am ET Initial results demonstrate potential of '444 in the treatment of patients with moderate to severe asthma LONDON and SOUTH SAN FRANCISCO, CA--(MARKET WIRE)--Dec 2, 2008 -- News ) today announced... Tue, 02 Dec 2008 13:24:00 GMT http://www.newstin.co.uk/tag/uk/91055668 2008-12-02T13:24:00Z http://www.newstin.co.uk/tag/uk/91009336 A collection of online educational materials are now available for free to consumers to help fend off the dangers of contaminated or counterfeit drugs. Unveiled today by the Partnership for Safe Medicines, "Consumer Resources"... Tue, 02 Dec 2008 10:16:00 GMT http://www.newstin.co.uk/tag/uk/91009336 2008-12-02T10:16:00Z http://www.newstin.co.uk/tag/uk/90988847 by: Mike Huckman December 02, 2008 | about stocks: Mike Huckman About this author: Time to pen our predictions for our beats in the new year. Analyst Barbara Ryan at Deutsche Bank says enough is enough, that these times call... Tue, 02 Dec 2008 08:26:00 GMT http://www.newstin.co.uk/tag/uk/90988847 2008-12-02T08:26:00Z